The intensive use of flow cytometry methods has identified a variety of T cells that could serve as potential markers for T1D, such as FOXP3 IFN-γ Tregs (100), CD4+ T cells IL-2 response (101) and IL-21 CD4+ T cells (102). This evidence concerns the gene FOXP3 and type 1 diabetes mellitus.